Evaluation of the Effects of Laughter Yoga
ConditionMultiple Sclerosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFirat University
About this trial
This randomized controlled study aims to evaluate the effects of laughter yoga on pain intensity, fatigue, and beta-endorphin levels in patients with Multiple Sclerosis. Laughter yoga, a complementary therapy combining breathing exercises and laughter techniques, may help improve symptom management and psychological well-being in individuals with MS.
Eligibility criteria
Qualifiers
• Being over 18 years old
Being able to communicate adequately
Volunteering to participate in the research
Disqualifiers
Unwillingness to participate in the study
Trial design
Treatments tested in this trial
- Laughter Yoga
Treatment groups
72 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov